Prestige Consumer Healthcare (PBH) Total Debt Growth (3y) (2014 - 2026)
Prestige Consumer Healthcare (PBH) Total Debt Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | 15.43% |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | -7.08% |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 11.33% |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -3.67% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | -10.43% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | -13.72% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 92.83% |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.37 Bn | - | -9.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.61% |
| Dec 31, 2025 | -10.13% |
| Sep 30, 2025 | -11.61% |
| Jun 30, 2025 | -12.31% |
| Mar 31, 2025 | -12.41% |
| Dec 31, 2024 | -13.46% |
| Sep 30, 2024 | -13.04% |
| Jun 30, 2024 | -10.95% |
| Mar 31, 2024 | -8.71% |
| Dec 31, 2023 | -8.17% |
| Sep 30, 2023 | -6.56% |
| Jun 30, 2023 | -6.69% |
| Mar 31, 2023 | -8.04% |
| Dec 31, 2022 | -5.76% |
| Sep 30, 2022 | -6.40% |
| Jun 30, 2022 | -6.12% |
| Mar 31, 2022 | -6.36% |
| Dec 31, 2021 | -6.00% |
| Sep 30, 2021 | -5.52% |
| Jun 30, 2021 | -8.14% |